CFIA
PKBO

Cantor Fitzgerald Investment Advisors’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Cantor Fitzgerald Investment Advisors’s Portfolio PKBO Stock Details PKBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$158K Hold
16,034
– – 0.01% 303
2021
Q4 		$156K Buy
+16,034
New +$157K 0.01% 302

Other funds holding PKBO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.97% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

Cantor Fitzgerald Investment Advisors's PKBO Position: Q1 2022 in Review

Cantor Fitzgerald Investment Advisors held its Peak Bio, Inc. Common Stock (PKBO) position steady in Q1 2022 at 16,034 shares worth $158K. The position accounts for 0.01% of the portfolio, ranked #303.

Cantor Fitzgerald Investment Advisors first reported a position in PKBO in Q4 2021 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold PKBO as of Q1 2022.

  • Cantor Fitzgerald Investment Advisors held 16,034 shares of Peak Bio, Inc. Common Stock worth $158K as of Q1 2022.
  • Cantor Fitzgerald Investment Advisors left its Peak Bio, Inc. Common Stock share count unchanged in Q1 2022.
  • Peak Bio, Inc. Common Stock made up 0.01% of Cantor Fitzgerald Investment Advisors's portfolio in Q1 2022, its #303 holding.
  • Cantor Fitzgerald Investment Advisors first reported a position in Peak Bio, Inc. Common Stock in Q4 2021 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q1 2022.

Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q1 2022, filed 13 Apr 2022.